Taiwan's integrated screening-to-cure cascade offers a practical path toward the WHO's 2030 hepatitis C elimination target, as chronic HCV continues to affect an estimated 50 million people worldwide.
Taiwan's Screening-to-Cure Model Advances Hepatitis C Elimination
Taiwan's integrated screening-to-cure cascade offers a practical path toward the WHO's 2030 hepatitis C elimination target, as chronic HCV continues to affect an estimated 50 million people worldwide.
![[Correspondence] Taiwan's path to hepatitis C elimination](https://nbg1.your-objectstorage.com/ckln/image-assets/6506d03f4e3c7be21930550a54b3d9307800077ae69296c34e963fb935d7b30a.jpg)
Hepatitis B vaccine · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.